Okay, here is the rub on CBIS. We all know that they are a Medical Marijuana play....pure and simple. To that extent, I look at them like any other bio-tech trying to get a drug to market, which is what they are trying to accomplish. Like any other bio-tech, they need to raise money to conduct trials to get FDA approval pure and simple.
So what is the pay-off? If they get the drup to trial phase and it is approved, big pay-off based on the billion dollar plus market for treating PTSD and other illenesses.
But like the other message, this is a long term play. I think the divy will boost the price somewhat for a short term, will I stay for the payout of shares, most likely. Why, because eventually, CBIS will announce advanced clinical trials for their products which will spike the price even higher. If that occurrs, I will sell my position and only keep my free shares....so if something gets approved, I will make a lot of money.....if it does not....then I still do not lose anything...who can argue with those odds!
